Europe Telemedicine Market Analysis Sample Report

EU Telemedicine
Market Analysis
A sample report on
www.insights10.com
Includes Market Size, Market Segmented by Types
and Key Competitors (Data forecasts from 2022 – 2030F)

This report presents a strategic analysis of EU Telemedicine Market and
a forecast for its development in the medium and long term. It provides a
comprehensive overview of the market value, dynamics, segmentation,
characteristics, main players, trends and insights, growth and demand
drivers, challenges & future outlook, etc. This is one of the most
comprehensive reports about the EU Telemedicine Market, and offers
unmatched value, accuracy, and expert insights

Table of
Contents
• Market Overview
• Growth Drivers & Restraints
• Market Segmentation
• Major Market Share
• Competitive Landscape
• Key Company Profiles
• Healthcare Policies & Regulatory Framework
• Factors Driving Future Growth
• Future Opportunities
• Conclusion

4 A Sample Report on Report Title I Confidential
Table of Contents
1. EU Telemedicine Market Overview ……………………………………………….…………………………...………………..….…………..…..09
1.1 Introduction
1.2 Market size and forecast
2. Market Growth Drivers and Restraints ……………………………..…………..…………………....…..........................................................12
2.1 Market Growth Drivers
2.1.1 Rising healthcare costs
2.1.2 Technological innovations
2.1.3 Increasing remote patient monitoring
2.1.4 Growing burden of chronic diseases
2.2 Market Restraints
2.2.1 Legal & reimbursement issues
2.2.2 High initial capital requirements and lack of physician support
3. Major Telemedicine Practices…………………………………………………………………….……………………………………………….…19
3.1 Store and Forward
3.2 Remote patient monitoring
3.3 Real-time telemedicine

Table of Contents (continued)
4. Telemedicine market segmentation…………….…………………………………..………………………………..…….……………….…..….21
4.1 By Type
4.2 By Clinical Services
4.3 By Mode of Delivery
4.4 By Region
5. EU Telemedicine Market Share By Application………………..………………………..……….……….………………..…………………..…28
5.1 Market Share by Application
5.2 Key Findings
6. Competitive Landscape………………………………………………………………………………………..…….………..……………..….……30
6.1 EU Regional Presence in Telemedicine
6.2 Major companies in EU Telemedicine market
6.3 Insights & Forecast (Company market position analysis)
6.4 Competitive Landscape- Various EU startups leveraging telemedicine platforms

7. Key Company Profiles (Company Overview, Product & Services, Strategies & Financials ) ….……………………...………………...35
7.1 Aerotel Medical Systems
7.2 Allscripts Healthcare Solutions
7.3 SHL Telemedicine Inc
7.4 Bio Telemetry Inc
7.5 IBM Corporation
7.6 Resideo Technologies Inc
7.7 Medtronic PLC
7.8 Koninklijke Philips NV
8. R&D initiatives by major companies………………………………….……………………………………………………..……………………..52
8.1 R&D Expenditure By Major Companies
8.2 R&D Initiatives- Insights

9. Access and Reimbursement Scenario…………………………………………………..……………….…………………………………….…..55
9.1 Region-specific reimbursement scenario-France
9.2 Region-specific reimbursement scenario-Spain
9.3 Region-specific reimbursement scenario-UK
9.4 Region-specific reimbursement scenario-Germany
9.5 Region-specific reimbursement scenario-Italy
9.6 Region-specific reimbursement scenario-Rest of EU
10. Factors Driving Future Growth………………………..……………………………………………….………..……………………….…….…..62
10.1 Key Industry Developments of Telemedicine market
10.2 Future Opportunities
10.3 Conclusion

“The opportunities for the deployment and adoption of
telemedicine across the EU are
triggered by a changing demography of both
individuals and medical professions; these
changes call for a search for optimization of the
healthcare service provision driven by the
perspectives of self-management and prevention”

EU Telemedicine Market Analysis
1. Overview

10 A Sample Report on EU Telemedicine Market I Confidential
1.1 Introduction
▪ Telemedicine or telehealth has emerged as an essential component of healthcare during the current COVID-19 crisis. The countries
not only in Europe but globally have accelerated the adoption of digital health
▪ As per the study published by the Paris Region Institute in April 2020, France has seen a major surge in teleconsultation from
10,000 teleconsultations per week before confinement to more than a million the last week of April, a multiplication by 100. This is
the major factor propelling the growth of the market
▪ The adoption of digital health has accelerated in countries all over the world, not just in Europe. According to a study published by
the Paris Region Institute in April 2020, teleconsultation in France has increased dramatically from 10,000 per week prior to
confinement to more than a million in the last week of April, a 100-fold increase. This is the primary driver of the market's growth
▪ For instance, according to the Global Cancer Statistics 2020, Europe is responsible for 22.8 % of all cancer cases and 19.6 % of
cancer deaths worldwide
▪ To take advantage of the potential opportunities, market players are developing technological innovations and launching new
products as growth drivers for their businesses and the market in this region. For example, in August 2020, HealthHero, a new
digital health company, was launched in the targeted European market

1.2 Market Size & Forecast Overview
Key Analysis
▪ The overall EU Telemedicine market will experience sizable
growth over the forecast period, increasing from $11.55 Bn
in 2022 to over $40.39 Bn in 2030 with a CAGR of 16.94%
▪ The market growth is attributed to factors like increasing
healthcare expenditure and increasing preference for
remote patient monitoring
▪ Content
▪ Content

2. Growth Drivers and Growth Restraints

Telemedicine Market Growth Drivers
Rising Healthcare Costs
Growing Burden Of Chronic
Diseases
Increasing Remote Patient
Monitoring
Technological Innovations

2.1 Market Growth Drivers
2.1.1 Rising Healthcare Costs
▪ Healthcare has become more expensive as the population expanded—people get older and live longer.
Therefore, 50% of the increasing healthcare costs is attributed to increased costs for services, especially
inpatient hospital care
▪ Among EU countries, Switzerland had the second-highest healthcare budget in 2019, with expenditures near
$8,000 per capita. Germany and Norway round out the top three, spending around $6,600 per capita each
▪ Content
▪ Content

Market Growth Drivers (continued)
▪ Telemedicine and all types of mixed reality (MR), such as augmented reality (AR) and virtual reality (VR) go
along very well. MR technologies let clinicians get real-time information on patients’ vitals and experiences,
which can improve the accuracy of remote diagnostics
▪ Robotics has forayed into various fields of telemedicine. Tele-robots make remote patient monitoring, diagnosis,
and virtual care easier and more accurate
▪ Content
▪ Content
2.1.2 Technological Advancement

2.1.3 Increasing Remote Patient Monitoring
▪ The Remote Patient Monitoring Technology market has attracted significant investment in the past decade and is
growing at an extraordinary rate
▪ It is expected to reach around 28 Bn euros by the end of 2023, this market is very attractive to many big name
companies that want to be ‘connected’ such as Qualcomm Life, Inc., OSI Systems, Inc., Philips Healthcare,
Abbott Laboratories and GE Healthcare among others
▪ In Netherlands, 51% of reduction in hospital cost was observed for COPD patients by using a Remote
Telemonitoring App
▪ Content
▪ Content

2.1.4 Growing Burden Of Chronic Diseases
▪ Chronic diseases represent the major share of the burden of disease in EU, and are responsible for 86% of all
deaths
▪ Over 50 Mn people in EU live with more than one chronic disease
▪ Content
▪ Content

2.2 Market Restraints
▪ Inadequate access to computing is a barrier to
telemedicine uptake for many developed countries
▪ Equipment, transport, maintenance, and training costs
for local staff can be daunting for countries with limited
funding for the implementation and maintenance of
telemedicine initiatives
▪ Physicians claim that telemedicine can never replace
an in-person examination of patients, and its use may
always be restricted only to some special scenarios
▪ Content
▪ In EU, the laws suggests that telemedicine is the
responsibility of the national government when
undertaken within the borders of that country and
subject to legal constraints within that country
▪ Many member states (MS) do not even have legal
instruments dealing specifically with telemedicine in
their own country, and only a few have regulations or
guidelines
▪ Content
2.2.1 Legal & Reimbursement Issues
2.2.2 High Initial Capital Requirements And Lack Of
Physical Support

3. Telemedicine Practices

3. Telemedicine Practices
Store and forward Remote patient monitoring
▪ Remote patient monitoring is one
specific form of telehealth that involves
using a device to collect and transmit
vital signs or physiologic data from a
patient outside of the office
▪ That data is monitored by clinical staff
and used for ongoing patient care,
communication, and education
▪ Store-and-forward telemedicine
surpasses the need for the
medical practitioner to meet in
person with a patient
▪ Instead, patient information such
as medical images or biosignals
can be sent to the specialist as
needed when it has been
acquired from the patient
▪ Real-time telemedicine (also called
live telemedicine) makes it easy to do
a doctor-patient visit anytime,
anywhere
▪ Live telemedicine includes any two-
way communications (including video
conferencing and phone
consultations) that let providers and
patients communicate in real-time
Real time telemedicine
3.1 3.2 3.3

4. Market Segmentation

EU Telemedicine Market Segmentation
Market
Restraints
By Clinical Service
By Mode Of Delivery
By Region
EU Telemedicine
Market
Segmentation
By Type

Snapshot of Gram-Negative Infection Therapeutics Market Segmentation
▪ Pathology
▪ Cardiology
▪ Surgery
▪ Radiology
▪ Oncology
▪ Other clinical services
By Type By Region
By Mode of Delivery
▪ On-Premise delivery
▪ Cloud-Based delivery
▪ Italy
▪ Germany
▪ Spain
▪ France
▪ United Kingdom
▪ Rest of EU
By Clinical Service
▪ Tele-Homes
▪ Tele-Hospitals
▪ mHealth

4.1 Market Segmentation: By Type
Telemedicine Market
EU Telemedicine Market Share by Type 2022
Type 2019 2021 2023 2025 2028
CAGR
(%)
Tele homes XX XX XX XX XX XX
Tele
hospitals
XX XX XX XX XX XX
mHealth XX XX XX XX XX XX
Revenue in USD Mn, by Service, EU, 2019-2028
▪ Based on type, the Telemedicine market is bifurcated into Tele hospitals, Tele homes and m Health. The Tele home segment held a
significant growth in 2019, and expected to grow at 19.5% in EU
▪ A significant growth would be observed in this segment, because of an extensive adoption of remote patient monitoring devices
Key Insights

4.2 Market Segmentation: By Clinical Service
Key Summary
EU Telemedicine Market Share by Clinical Service
2022
▪ Pathology has witnessed the highest growth in 2019, and
expected to observe a soar rise during the forecast period
▪ Pathology segment enables the transfer of image-rich
data between distant locations for the purposes of
diagnosis, and research
▪ The surgery allows patient to reduce cost and travel time
associated with post-surgical treatment, which will boost
the segmental growth
▪ Content
▪ Content

4.3 Market Segmentation: By Mode of Delivery
Key Summary
EU Telemedicine Market Share by Mode of Delivery
2022
▪ The Cloud Based Delivery has witnessed a significant
growth in 2019, and expected to capture a major share
during the forecast period
▪ One of the factors contributing to the market share is
supportive government initiatives to speed up digitalization
across all economic sectors
▪ For instance, the French government introduced Cloud
Strategy for the use of cloud computing by the
administration
▪ Content
▪ Content

4.4 Market Segmentation: By Region
Key Summary
EU Telemedicine Market Share by Region 2022
▪ In 2022, UK has witnessed a significant growth in the
Telemedicine Market due to increase in technology
advancements and use of smartphones
▪ UK HealthCare Telecare functions similarly to an urgent
care clinic, making it easy for patients with acute-onset
symptoms to get expert care without leaving home
▪ In the past years, Spain Telemedicine Market has observed
a decline in the market revenue share
▪ However, Spain Telemedicine Market will observe a
significant growth of 18.9% during the forecast period
Rest of EU
United Kingdom
Germany
Italy
France
Spain
Column1

5. Telemedicine Service Market Share

5.1 Major Market Share By Application
Key Insights
Telemedicine Major Market Share by Application
▪ The Telemedicine by application indicates that
Telemonitoring and Teleconsulting comprised of nearly
50% of the market share
▪ Telemonitoring alone accounted for approximately 22%
share in the year 2019, because of IoMT
▪ IoMT is accelerating digital transformation of healthcare
using a range of technologies aimed at diagnosing &
monitoring patients more effectively
▪ Content

6. Competitive Landscape

6.1 Competitive Landscape – EU Regional Presence

6.2 Competitive Landscape: Key Players Revenue
(Current and Forecasted)
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Koninklijke Philips
NV
5.56 $xx $xx $xx $xx $xx $xx $xx $xx $xx
Medtronic PLC. 8.6 $xx $xx $xx $xx $xx $xx $xx $xx $xx
Aerotel Medical
Systems
XX $xx $xx $xx $xx $xx $xx $xx $xx $xx
Allscripts
Healthcare
1.77 $xx $xx $xx $xx $xx $xx $xx $xx $xx
SHL Telemedicine 0.041 $xx $xx $xx $xx $xx $xx $xx $xx $xx
Bio Telemetry Inc. XX $xx $xx $xx $xx $xx $xx $xx $xx $xx
IBM Corporation XX $xx $xx $xx $xx $xx $xx $xx $xx $xx
Residio Technology XX $xx $xx $xx $xx $xx $xx $xx $xx $xx
Major Market Sales of Telemedicine Companies in EU ($Bn)

6.3 Competitive Landscape- Insights and Forecast
Key Insights
▪ Medtronic PLC, followed by IBM Corporation has the
highest market sales in the year 2019, and are expected
to exhibit the highest share during the forecast period
▪ Technological advancements currently going on in these
big health techs will drive the EU market further
▪ Technologies like the IBM Cloud, helps ensure one’s
solution’s scalability, and IBM Security solutions assist in
protecting patients’ information
▪ Content

6.4 Competitive Landscape- Various EU startups leveraging telemedicine
platforms
Telemedico is a telemedicine platform for insurance and assistance companies from over 15 countries. Telemedico
is also integrating its solutions with various medical devices and implementing new technologies such as AI
(Poland)
(Luxembourg)
(France)
(Switzerland)
(Italy)
(Spain)
Docline is a telemedicine solution for insurance, healthcare providers and patients etc. Docline introduced an
innovative QR based e-prescriptions. The platform’s medical network consists of 1,500 doctors spanning over 25
specialties
DoctorsinItaly is a platform helping tourists find an English speaking doctor for both online & in person consultations.
The platform connects patients, practitioners, medical specialists, and mental health professionals
Derma2go is an online platform connecting patients with dermatologists who carry out on online diagnosis within 24
hours. Patients also receive a referral for an in person consultation and have medication delivered to homes
Doctena is a medical booking platform helping patients and doctors schedule their medical appointment in 6 EU
countries. The solution also enables doctors to manage reimbursements and issue prescriptions in the countries
where it is permitted
Consulib is a telemedicine platform available to all doctors in France without subscription or onboarding fees. The
platform also enables doctors to issue e-prescriptions, receive electronic medical records and manage payments.
More than 6000 doctors are registered on the startup’s platform

7. Key Company Profiles

7.1 Koninklijke Philips NV
Company Profile
▪ Philips was formerly one of the largest electronics
companies in the world, currently focused in the area of
health technology, with other divisions being divested
▪ Philips is organized into three main divisions: Personal
Health, Connected Care, and Diagnosis & Treatment
▪ In December 2020, Philips and Bio Telemetry, Inc., a
leading U.S.-based provider of remote cardiac diagnostics
and monitoring, announced that they had entered into a
definitive merger agreement
▪ In January 2021, Philips announced the acquisition of
Capsule Technologies, Inc., a provider of medical device
integration and data technologies for hospitals and
healthcare organizations
Company Name: Koninklijke Philips NV
Year of Establishment: 1891
Headquarter: Amsterdam
Revenue: €19.535 Bn
www.philips.com

Koninklijke Philips NV
Breakdown of net revenue by segment, 2022
Revenues ($Bn), 2021-2030F
Analysis
1 2 3 4
XX
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
$XX Bn

7.2 Medtronic PLC
Company Profile Company Name: Medtronic PLC
Year of Establishment:
Headquarter:
Revenue:
Website:
Sample

Medtronic PLC (Continued)
Sample
Analysis
1 2 3 4
XX
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
$XX Bn

7.3 Aerotel Medical Systems
Company Profile Company Name: Aerotel Medical Systems
Headquarter:
Revenue:
Website:
Sample

Aerotel Medical Systems (Continued)
Sample
Analysis
1 2 3 4
XX
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
$XX Bn

7.4 AllScripts Healthcare
Company Profile
Company Name: AllScripts Healthcare
Headquarter:
Revenue:
Website:
Sample

AllScripts Healthcare (Continued)
Breakdown of net revenue (%) by segment, 2021
Analysis
Revenues ($Bn), 2021-2030
XX
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
XX
Sample

7.5 SHL Telemedicine
Company Profile
Company Name: SHL Telemedicine.
Headquarter:
Revenue:
Website:
Sample

SHL Telemedicine (Continued)
Sample
Analysis
1 2 3 4
XX
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
$XX Bn

7.6 Bio Telemetry Inc
Company Profile
Company Name: Bio Telemetry Inc
Headquarter:
Revenue:
Website:
Sample

Bio Telemetry Inc (Continued)
Sample
Analysis
1 2 3 4
XX
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
$XX Bn

7.7 IBM Corporation
Company Profile
Company Name: IBM Corporation
Headquarter:
Revenue:
Website:
Sample

IBM Corporation (Continued)
Sample
Analysis
1 2 3 4
XX
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
$XX Bn

7.8 Resideo Technology
Company Profile
Company Name: Resideo Technology
Headquarter:
Revenue:
Website:
Sample

Resideo Technology (Continued)
Sample
Analysis
1 2 3 4
XX
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
$XX Bn

8. R&D Initiatives by Major Players

8.1 R&D Expenditure By Major Companies
▪ Koninklijke Philips, followed by Medtronic PLC has the
highest contribution in the R&D expenditure for the
telemedicine
▪ The lowest R&D expenditure among the top players
was contributed by SHL Telemedicine. The expenditure
reduced from 2018 by 13%, which was attributed to
capitalization of development costs
Key Insights
Sample
EU Telemedicine Market-R&D Expenditure of major
companies ($Bn), 2022

8.2 R&D Initiatives- Insights
Sample
▪ In 2019, Philips to acquire
BioTelemetry, Inc. for USD 72.00 per
share; implied enterprise value of USD
2.8 Bn
▪ Acquisition is a strong fit with a
combination of Philips’ leading patient
monitoring position in the hospital with
BioTelemetry’s leading cardiac
diagnostics and monitoring position
outside the hospital
▪ With 2019 sales of USD 439 Mn,
BioTelemetry annually monitors over 1
Mn cardiac patients remotely; its
portfolio includes wearable heart
monitors, AI-based data analytics and
services
▪ Teleclinic delivers security-rich
telemedicine services to patients
throughout Germany
▪ Teleclinic has launched its telemedicine
platform in a private IBM Cloud
environment and implements a security-
rich IBM Cloudant database layer
▪ Teleclinic provides 400,000 patients
across Germany with convenient digital
access to medical expertise and
anticipates powering intelligent health
predictions with IBM Watson technology
Acquired

9. Access and Reimbursement Scenario

9.1 Access and reimbursement scenario- France
▪ The French Government and Parliament have been encouraging the development of telemedicine, and the reimbursement of
telemedicine acts by the social security administration through the National Health Insurance Program has developed over the
past ten years
▪ Content
▪ Telemedicine is allowed in France and governed by FCPH Art
▪ Telemedicine services can only be provided by healthcare
professionals or healthcare organizations such as hospitals
▪ It can only be performed with the informed consent of
patients
▪ It also must ensure the professional’s access to the personal
medical data of the patients which are necessary for his or
her treatment
General Reimbursement Environment
Key Market Access Considerations

9.2 Access and reimbursement scenario- Spain
▪ In Spain, Both public and private sector cover telemedicine services
▪ Public reimbursement for telemedicine services is not covered in Spanish legislation, except for cross-border healthcare assistance
pursuant to Royal
▪ The Royal Decree states that the relevant public healthcare administration will reimburse the corresponding expenses. Private
healthcare insurance may reimburse some telemedicine services
▪ Content
▪ Telemedicine is generally allowed in Spain
▪ There are no expressly stated limitations or restrictions
applicable to telemedicine under Spanish law
▪ Each AACC healthcare authority has the autonomy to plan,
change and upgrade their healthcare infrastructures
▪ The Code of Medical Ethics of the General Council of
Medical Associations of Spain considers the practice of
medicine exclusively by means of internet unethical

9.3 Access and reimbursement scenario- United Kingdom
▪ It is provided within the National Health Service (NHS), telemedicine will be free at the point of delivery, and funded by UK
taxpayers’ National Insurance contributions
▪ GPatHand is a free NHS funded service. There are no additional legal requirements for the telemedical industry in the UK
▪ Content
▪ Telemedicine is generally allowed in the UK
▪ Article 8 of the directive requires member states to control
whether healthcare professionals are respecting their
professional rules when offering these services
▪ Directive on consumer rights applies where an individual
purchases an app relating to health/ lifestyle/wellbeing
▪ Post Brexit, the E-Commerce Directive will continue to
apply to the UK for the duration of the transition period

9.4 Access and reimbursement scenario- Germany
▪ In the past, only some telemedicine services were reimbursed by health insurance providers in Germany, significantly more so by
the private health insurance providers than by the public health insurance providers
▪ However, both numbers are increasing. Due to regulatory changes regarding telemedicine, the conditions for the reimbursement of
telemedicine services have changed accordingly, for example: – Video consultation hours are now not only reimbursed by the
private health insurance providers, but also by the public health insurance providers
▪ Content
▪ Telemedicine services are generally allowed, if they are used in
addition to personal contact
▪ Since legalization of remote treatment in 2018, it is also
permitted to provide medical advice or treatment exclusively
▪ The new Digital Healthcare Act which came into force in
January 2020, now allows physicians to inform about and
advertise telemedicine services on their website

9.5 Access and reimbursement scenario- Italy
▪ The Italian Guidelines on Telemedicine expressly provide that, as for all the other medical activities, telemedicine tools can be
charged to the National Health Service (NHS)
▪ Both the public and private sector cover telemedicine services. In particular, as noted in the IVASS (Institute for Insurance
Supervision) report on the new health policies on digital health insurance dated October 2016, private health insurance covers many
telemedicine services
▪ Content
Sample

9.6 Access and reimbursement scenario- Rest of EU
Sample
Sample

10. Future Development Growth

10.1 Key Industry Developments
▪ Luscii was founded in 2018, and uses a mobile app to help prevent unnecessary hospital visits and admissions for
vulnerable patients by increasing access to clinical support and the improving the patient experience
▪ Luscii is now active in seven countries of EU and has secured worldwide partnerships with Apple and Omron
▪ Fifty per cent of Dutch hospitals are using Luscii and it has extended its services internationally (Ireland, Sweden, UK,
Netherlands
▪ The platform handled up to 15 Mn virtual care interactions between June and January 2020
▪ In light of the growing demand to shift medical care closer to home, Healthy.io launched the first direct-to-consumer UTI test
and treat service on May 5, 2020, called ‘Velieve’
▪ With Velieve, women can have a urinalysis kit delivered to their homes, use their smartphone to complete the test, have
results assessed by an online doctor, and, where indicated, have antibiotics delivered to their homes within hours
Content

10.2 Future Opportunities
▪ Researchers with the EU-funded THALEA II project are pushing an innovative telemedicine system for Intensive Care Units
(ICUs) to market using a process called public procurement of innovative solutions. Assisted by ICT for Life, this project is
saving co-morbid patients in Europe as part of a Patient personalized care program of the EU
▪ Robotics is a promising cutting-edge and a futuristic tool in telemedicine that has potential applications in transforming
physical exam and clinical care, as well as monitoring patients in remote conditions
▪ The Society of European Robotic Gynecological Surgery has released guidelines for robot-assisted surgery (RAS) and
promoted the use of RAS over conventional laparoscopic and open surgery in managing infection risk
Content

10.3 Conclusion
▪ Healthcare systems across EU are facing unprecedented pressure. While the quantity and quality of care has improved, the scale
and complexity of healthcare needs have grown, together with public expectations of more personalized and convenient services
▪ Telemedicine grew from less than 1% of primary care visits to nearly 43.5% in April 2020. With telemedicine’s current trajectory and
rapid adoption rate, it has the potential to disrupt and redefine the way health systems operate, deliver care and manage costs,
setting the stage for a vastly different healthcare experience in the future
▪ The end-goal of eHealth is the shift in the focus of healthcare provision from a doctor and hospital-centric approach to a patient and
wellness-centric focus, through the use of digital technologies
▪ With patients growing more accustomed to virtual care, health systems that lack telemedicine access will see decreased patient
volumes from patients choosing providers that do offer telemedicine
▪ The EC made a number of commitments to drive digital transformation like the development of EU-wide standards for data quality,
reliability and cybersecurity giving citizens secure access to a comprehensive electronic record of their personal health data
▪ The EC also highlighted the need to take account of emerging technologies such as blockchain, innovative identity management and
certification mechanisms. The technological advancements and a rising population would fuel the telemedicine market in the EU

Research Methodology
▪ Insights 10’s research methodology delves deeper into the market, covering the macro and micro aspects of the industry. We identify the
key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive
overview of the competitive landscape to help our clients make informed strategic decisions
▪ We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial
phase of our study where we conduct extensive data mining, referring to verified data sources such as independent studies, government
and regulatory published material, technical journals, trade magazines, and paid data sources
▪ For forecasting, the following parameters are considered:
❑ Market drivers and restraints along with their current and expected impacts
❑ Technological scenario and expected developments
❑ End use industry trends and dynamics
❑ Trends in the consumer behavior
❑ Regulatory scenario and expected developments
❑ Current capacity and expected capacity additions up to 2030
▪ We assign weights to these parameters and quantify their market impacts using the weighted average analysis to derive the expected
market growth rate
▪ We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time-
sensitive, reflecting the most recent value and volume of the market across regions
▪ All our estimates and forecasts are verified through exhaustive primary research with the Key Industry Participants (KIPs)
▪ Currency used in the report is the US dollar (USD), with the market size indicated in USD million/billion (Mn/Bn)

Analysis Methodology
Our Analysis Methodology involves three critical stages:
Primary
Research
Secondary
Research
Market Trends
Market Sizing &
Analysis
Data Triangulation &
Validation
Analysis &
Interpretation
Insights
Presentation &
Reporting
Data Collection
Market Data Analysis
& Statistical Model
Interpretation &
Presentation

Data Triangulation & Data Validation
Bottom Up Approach
Summarization of revenue
generated from companies
to arrive at total market size
Revenue generated by products &
services offered by companies
Validation from
Primary Interview
Final
Market
Size
Top Down Approach
Final Market size break up to
rest of segmentation
Arriving at market size
of each segment
Validation from
Primary Interview
Final
Summary

Key Benefits for Stakeholders from this Report
Study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent
investment pockets
Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and
quantitative industry variables
Comprehensive analysis of factors that drive and restrict the market growth is provided
Comprehensive quantitative analysis of the industry from 2022 to 2030F is provided to enable the stakeholders to capitalize on
the prevailing market opportunities
Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally
Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater
understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors

2021
2022-
2030
Report Attribute
Quantitative Units
Report Coverage
Customized Report
Pricing and purchase
options
Revenue in USD Million/Billion (Mn/Bn)
Market Overview, Revenue Forecast, Market
Segmentation, Growth Factors and Trends,
Company Profiles, Competitive Landscape,
Regulatory Landscape, Future Opportunities
Report Customization (5 working days) with
purchase. We will provide you with data that is
currently not a part of our scope as a part of
customization
Avail customized purchase options to meet
your exact research needs
Details
Time Frame
Base Year for
Estimation
Forecast
Period

The report is prepared
using a proven
methodology and insightful
research
Reliable
The data is prepared by a
team of highly qualified &
experienced research
analysts & vetted by our
local associates
Expert-verified
Allowing you to confidently
make smarter business and
strategic decisions
Real
Covers everything you
would need to know about
the market including
market size, competitive
analysis & much more
Comprehensive
You do not have to be a
market expert to
understand what really is
happening on the market
and how it works
Easy to read
What kind of Data is Presented
in this Report?
This report presents data, which is:
www.insights10.com

www.insights10.com
A large database of over 30,000 syndicated market
research reports in pharmaceuticals and
healthcare sector at global, regional as well as
country level. We also provide customized
research reports tailor made to suit your needs
Lifesciences Market
Research Reports you
can trust

Insights10 is a healthcare focused market
research firm founded with an aim of being an
insights driven company in the data driven world
and delivering actionable insights that can drive
decision and strategy making process for
businesses
Get Insights to take
informed Business
Decisions
www.insights10.com

Market Research Reports
across various domains of healthcare
Healthcare
Services
Clinical
Trials
OTC &
Nutraceuticals
Pharmaceuticals
(Diseases & Drugs)
Digital
Health
Medical
Devices

Our
Services
1
2
3
4
5
6
10
9
8
7
Market Research Reports
Customized Reports
Primary Research
Database Services
Full-Time Engagement
Conference Coverage
Competitive Intelligence
Strategic Research Projects Regulatory Compliance
Report Subscription Services

Our Research Process
01 03
02 04 05
Identification of
Data
Collection of
Data
Market
Dynamics
Collaboration
of Data
Verification &
Analysis
www.insights10.com

Statistical Databases
Data
Sources
We have access to multiple highly
reliable free and subscription data
sources. We have many years of
experience to understand which
sources are more dependable for what
and which to prefer for the reliable and
latest information.
Company Websites/Annual Reports
Trade Publications
Online Databases
Published Research Reports
Whitepapers
Press Releases of Key Market Players
www.insights10.com

Research Projects Done
Over the years, we have developed an in-depth experience of executing
market analysis at global, regional & country specific level in life sciences.
Our team has
conducted market
research across 62+
global markets in
America, Europe,
Middle East, Africa and
Asia Pacific regions

Mukesh is an engineering graduate
with an MBA in Marketing. He is a
seasoned healthcare market
research & marketing professional
with a progressive experience of over
20 years in Life Sciences, Pharma
and Medical Device sectors. With an
in-depth understanding of primary
research, he has conducted
hundreds of interviews of various
stakeholders in pharma & healthcare
& completed several research
projects across life sciences industry.
Ritu has over 6 years of experience in
strategy building, market assessments,
market sizing, and RWE for global MNC
healthcare & biopharma clients across
diff. markets (America, Europe, Africa,
APAC and Middle East). Her areas of
expertise include: Indentifying emerging
trends in life sciences industry,
Competitor landscape assessment,
Disease opportunity assessments etc.
She is a pro in secondary and primary
research with a deep domain expertise
in healthcare sector.
Purav is a physician and an
entrepreneur with 12+ years of
experience in Healthcare & Life
Sciences industry spanning across
strategy, market access, health
informatics and RWE, digital health,
analytics and data science. Purav
studied medicine from Gujarat
University and also completed his MBA
from IIM-Kozhikode. Purav started his
career with Deloitte working on strategy
consulting engagements and also co-
founded ConvergeHealth by Deloitte.
Dhruv Joshi is an engineer and has done
Masters in Hospital Administration with
over 4 years of experience in the
healthcare and life science industry. He
has gained proficiency in market
research, market assessment, and
developing insights from it. He has
worked on various consulting projects
across different geographies including
Asia, Europe, US, MENA. He has been
aligned in working for sector reports of
various geographies along with market
sizing and forecasting.
Dr. Purav Gandhi
Founder & CEO
Mukesh Nayak
Head - Marketing
Ritu Baliya
Engagement Manager
Dhruv Joshi
Consultant
Project Leadership Team

7 years of experience working with leading organizations in pharma, MedTech
and healthcare domain. Some of our recent clients are mentioned below
… and many more

Web: www.insights10.com
Email: insights@insights10.com
Call: (+91) 931 639 7935
WhatsApp: (+91) 931 639 7935
We would be happy to help.

Europe Telemedicine Market Analysis Sample Report

Recommended

Recommended

More Related Content

Similar to Europe Telemedicine Market Analysis Sample Report

Similar to Europe Telemedicine Market Analysis Sample Report (20)

More from Insights10

More from Insights10 (20)

Recently uploaded

Recently uploaded (20)

Europe Telemedicine Market Analysis Sample Report